<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01019447</url>
  </required_header>
  <id_info>
    <org_study_id>INDV-0909001</org_study_id>
    <nct_id>NCT01019447</nct_id>
  </id_info>
  <brief_title>The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection</brief_title>
  <official_title>&quot;The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection&quot; Prospective, Randomized, Controlled, Double Blind, Multi-centre Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amygate Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare conventional polyglactin 910 sutures with triclosan-coated polyglactin 910
      antimicrobial sutures for the reduction of surgical site infections and any associated health
      and economic benefits.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Signs of Surgical Site Infections (SSI) according to Centers for Disease Control (CDC) criteria</measure>
    <time_frame>30 days (or 1 year in case of prosthesis)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative hospital stay in days</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">701</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The study group in which Triclosan-coated polyglactin 910 antimicrobial sutures will be used.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group in which polyglactin 910 antimicrobial sutures will be used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vicryl Plus</intervention_name>
    <description>Triclosan-coated polyglactin 910 antimicrobial sutures (Vicryl Plus)</description>
    <arm_group_label>Study group</arm_group_label>
    <other_name>Triclosan-coated polyglactin 910 antimicrobial sutures</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vicryl</intervention_name>
    <description>Polyglactin 910 antimicrobial sutures (Vicryl)</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Polyglactin 910 antimicrobial sutures</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients of different age

          -  Gender

          -  Risk factors and procedures candidate for surgical intervention during the period of
             the study

        Exclusion Criteria:

          -  Patients with an established pre-operative infection at the operative site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim Ga Ibrahim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Al-Zeraaein Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cairo University Kasr Al-Aini Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2009</study_first_submitted>
  <study_first_submitted_qc>November 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>June 21, 2011</last_update_submitted>
  <last_update_submitted_qc>June 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ibrahim Galal Ibrahim</name_title>
    <organization>Cairo University Kasr Al-Aini Hospitals</organization>
  </responsible_party>
  <keyword>Surgical site infection</keyword>
  <keyword>Antimicrobial triclosan-coated polyglactin 910 suture</keyword>
  <keyword>Length of hospital stay</keyword>
  <keyword>SSI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Triclosan</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

